Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies

References

• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–9.
   PubMed Web of Science ®Google Scholar
• Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister Alt Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510–3.
   PubMed Web of Science ®Google Scholar
• Reed PI, Johnston BJ. The changing incidence of oesophageal cancer. Endoscopy 1993; 25: 606–8.
   PubMedGoogle Scholar
• Sihvo EIT, Sahninen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: Has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000; 35: 1082–6.
   Google Scholar
• Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 613–34.
   PubMedGoogle Scholar
• Nestmann ER, Bryant DW, Carr CJ. Toxicological significance of DNA adducts: summary of discussions with an expert panel. Regul Toxicol Pharmacol 1996; 24: 9–18.
   PubMed Web of Science ®Google Scholar
• Beach AC, Gupta RC. Human biomonitoting and the 32P-postlabeling assay. Carcinogenesis 1992; 13: 1053–74.
   PubMed Web of Science ®Google Scholar
• Krieh E, Rojas M, Alexandrov K, Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res 1998; 400: 215–31.
   PubMedGoogle Scholar
• Kure E, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, et al. p53 mutations in lung tumors: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996; 17: 2201–5.
   PubMed Web of Science ®Google Scholar
• Flamini G, Romano G, Curigliano G, Chiominto A, Capelli G, Boninsegna A, et al. 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study. Carcinogenesis 1998; 19: 353–7.
   PubMedGoogle Scholar
• Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996; 56: 287–93.
   PubMed Web of Science ®Google Scholar
• Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, et at. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 1998; 58: 38–41.
   PubMed Web of Science ®Google Scholar
• Lee BM, jang JJ, Kim HS. Benzo[a]pytene diol-epoxide-I-DNA and oxidative DNA adducts associated with gastric adenocarcinoma. Cancer Lett 1998; 125: 61–8.
   PubMed Web of Science ®Google Scholar
• Poirier MC. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ Health Perspect 1997; 105(Suppl 4): 907–12.
   PubMedGoogle Scholar
• Bremner CG, Lynch VP, Ellis FR Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1978; 68: 209–16.
   Google Scholar
• Salo JA, Kivilaakso EO, Kiviluoto TA, Virtanen IO. Cytokeratin profile suggests metaplastic epithelial transformation in Barrett's oesophagus. Ann Med 1996; 28: 305–9.
   PubMed Web of Science ®Google Scholar
• Gupta RC. Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 1984; 81: 6943–7.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Widlak P, Hou S-M. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis 1995; 16: 1661–4.
   PubMed Web of Science ®Google Scholar
• Umbenhauer D, Wild CP, Montesano R, Safthill R, Boyle JM, Huh N, et al. O(6)-methyldeoxyguanosirr in oesopha-geal DNA among individuals at high risk of oesophageal cancer. Int J Cancer 1985; 36: 661–5.
   PubMed Web of Science ®Google Scholar
• Lu SH, Ruggero M, Zhang MS., Feng L, Luo FJ., Chui SX, et al. Relevance of N-nitrosamines to esophageal cancer in China. J Cell Physiol 1986; (Suppl 4): 51–8.
   PubMedGoogle Scholar
• Izzotti A, Balansky RM, Blagoeva PM, Mircheva ZI, Tulimiero L, Cartiglia C, et al. DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J 1998; 12: 753–8.
   PubMed Web of Science ®Google Scholar
• Singh P, Taylor RH, Colin-Jones DG. Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitis: comparison between two positions. Gut 1994; 35: 304–8.
   PubMedGoogle Scholar
• De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, et al. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat Res 1996; 366: 197–238.
   PubMed Web of Science ®Google Scholar
• Siurala M, Lehtola J, Ihamäki T. Atrophic gastritis and its sequale. Results of 19-23 years' follow-up examinations. Scand J Gas troenterol 1974; 9: 441–6.
   PubMed Web of Science ®Google Scholar
• Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, et al. Colorectal cancer in patients with ulcerative colitis. Gastroenterology 1988; 94: 870–7.
   PubMed Web of Science ®Google Scholar
• Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, Mohr U, et at. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 1993; 55: 1386–93.
   PubMed Web of Science ®Google Scholar
• Sahninen JT, Tuominen JA, Ramo OJ, Färkkilä MA, Salo JA. Esophageal acid exposure in Barrett's esophagus: higher than in reflux esophagitis. Ann Med 1999; 31: 46–50.
   Google Scholar
• Vaezi MF, Richter JE. Synergism of acid and duodenogas-troesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699–704.
   PubMed Web of Science ®Google Scholar
• Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170: 552–6.
   PubMed Web of Science ®Google Scholar
• Sahninen JT, Ramo OJ, Färkkilä MA, Salo JA. Endogenous radical scavengers in Barrett's esophagus. Gastroenterology 1998; 114: G1128(A).
   Google Scholar
• Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994; 54: 3171–2.
   PubMed Web of Science ®Google Scholar
• Matins DC, Holmes EH, Polissar NIL, Gunselman SJ. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993; 71: 3036–43.
   PubMedGoogle Scholar
• Scates DK, Spigelman AD, Phillips RKS, Venitt S. The use of 32P-poslabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients. Mutat Res 1997; 378: 113–25.
   PubMedGoogle Scholar
• Lagergren J, Bergstrom R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31.
   PubMed Web of Science ®Google Scholar